Propionibacterium acnes endophthalmitis requiring intraocular lens removal after failure of medical therapy.
A 52-year-old Saudi man developed intraocular inflammation 7 weeks after uneventful phacoemulsification with implantation of a silicone posterior chamber intraocular lens (IOL). Cultures from the aqueous and vitreous were repeatedly negative, but a temporary response to intracameral and intravitreal injection of vancomycin was noted. A series of 6 intraocular injections given over 5 days failed to resolve the inflammation. It did, however, disappear after the IOL was removed. The IOL provided the only positive culture in this case of Propionibacterium acnes endophthalmitis. Nine months later, a posterior chamber poly(methyl methacrylate) IOL was implanted. Eighteen months later, the patient had no recurrences. He regained a visual acuity of 20/30, corresponding to his best postoperative result.
Teichmann
K D
KD
King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D020878:Device Removal; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D006801:Humans; D019654:Lens Implantation, Intraocular; D007910:Lenses, Intraocular / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D011425:Propionibacterium acnes / Q000302:isolation & purification*; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D012086:Reoperation; D014640:Vancomycin / Q000008:administration & dosage; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D014640:Vancomycin